Skip to main content
Log in

MMTV-induced mutations in mouse mammary tumors: Their potential relevance to human breast cancer

  • Virally-induced rodent models
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

In mouse mammary tumor virus (MMTV) infected mice, three identifiable stages of mammary tumorigenesis can be biologically defined: preneoplastic hyperplastic nodules, malignant tumor, and distant metastatic lesions (primarily in the lung). MMTV is a biological carcinogen which induces somatic mutations as consequence of its integration into the host cellular genome. Each stage of mammary tumorigenesis appears to result from the clonal outgrowth of cells containing additional integrated proviral MMTV genomes. This phenomenon has provided the basis for an approach to identify genes which, when affected, may contribute to progression through the different stages of mammary tumorigenesis. Eight different genes (Wnt1, Wnt3, Wnt10b, Fgf3, Fgf4, Fgf8, Int3, andInt6) have been shown to be genetically altered in multiple mammary tumors as a consequence of MMTV integration. Although the significance of the human homologs of these genes as targets for somatic mutation during human breast carcinogenesis is only now being explored, it is clear that this work has led to a new appreciation of the complexity of the genetic circuitry that is involved in the control of normal mammary gland growth and development. It seems likely that some of the mutations induced by MMTV, and the signaling pathways in which these target genes take part, will be relevant to the progression from preneoplastic lesions to distant metastasis in human breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gompel G, van Kerkem C: The breast.In: Silverberg S (ed) Principles of Surgical Pathology. Wiley Medical, New York, 1983

    Google Scholar 

  2. Harris JR, Hellman S, Canellos GP, Fisher B: Cancer of the breast.In: DeVita VT (ed) Cancer Principles and Practice of Oncology. J.B. Lippincott, Philadelphia, 1982

    Google Scholar 

  3. Lynch HT, Albano WA, Danes S, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA, Tindall SL: Genetic predisposition to breast cancer. Cancer 53:612–622, 1984

    PubMed  Google Scholar 

  4. Trent JM: Cytogenetic and molecular biologic alterations in human breast cancer: a review. Breast Cancer Res Treat 5:221–229, 1985

    PubMed  Google Scholar 

  5. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic mapping. Proc Natl Acad Sci USA 91:2156–2160, 1994

    PubMed  Google Scholar 

  6. Callahan R, Salomon DS: Oncogenes, tumour suppressor genes and growth factors in breast cancer: Novel targets for diagnosis, prognosis and therapy. Cancer Surveys 18:35–56, 1993

    PubMed  Google Scholar 

  7. Hollingsworth RE, Lee W-H: Tumor suppressor genes: new prospect for cancer research. J Natl Cancer Inst 83:91–96, 1991

    PubMed  Google Scholar 

  8. Knudson AG: Hereditary cancers: clue to mechanisms of carcinogenesis. Br J Cancer 59:661–666, 1989

    PubMed  Google Scholar 

  9. Bieche I, Champeme MH, Merlo G, Larsen CJ, Callahan R, Lidereau R: Loss of heterozygosity of the L-myc oncogene in human breast tumors. Hum Genet 85:101–105, 1990

    PubMed  Google Scholar 

  10. Merlo GR, Siddiqui J, Cropp CS, Liscia DS, Lidereau R, Callahan R: Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. Cancer Res 49:6966–6971, 1989

    PubMed  Google Scholar 

  11. Ali IU, Meissner S, Lidereau R, Callahan R: Allelic deletion of c-erbA-2 proto-oncogene in human breast carcinoma signifies possible recessive mutation in member(s) of steroid/thyroid hormone receptor family. J Natl Cancer Inst 81:1815–1820, 1989

    PubMed  Google Scholar 

  12. Devilee P, van Vliet M, van Sloun P, Kuipers-Dijkshoom N: Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6:1705–1711, 1991

    PubMed  Google Scholar 

  13. Orphanos V, McGown G, Hey Y, Boyle JM, Santibanez-Koref M: Proximal 6, a region showing allele loss in primary human breast cancer. Br J Cancer 71:290–293, 1995

    PubMed  Google Scholar 

  14. Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R: Loss of heterozygosity on chromosome 7q associated with aggressive human primary breast tumours. Lancet 339:139–143, 1992

    PubMed  Google Scholar 

  15. Ali IU, Lidereau R, Theillet C, Callahan R: Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science 238:185–188, 1987

    PubMed  Google Scholar 

  16. Theillet C, Lidereau R, Escot C, et al: Frequent loss of a H-ras-1 allele correlates with aggressive human primary breast carcinomas. Cancer Res 46:4776–4781, 1986

    PubMed  Google Scholar 

  17. Varley J, Armour J, Swallow JE, Jeffreys AJ, Ponder BAJ, T'Ang A, Fung YKT, Brammar W, Walker RA: The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 4:725–729, 1989

    PubMed  Google Scholar 

  18. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Meera Khan P, Pearson P, Cornelisse C: At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5:554–560, 1989

    PubMed  Google Scholar 

  19. Merlo G, Venesio T, Bernardi A, Canale L, Gaglia P, Lauro D, Cappa APM, Callahan R, Liscia DS: Loss of heterozygosity on chromosome 17p 13 in breast carcinomas identifies tumors with a high proliferation index. Am J Pathol 140:215–223, 1992

    PubMed  Google Scholar 

  20. Cropp C, Lidereau R, Campbell G, Champeme M-H, Callahan R: Loss of heterozygosity on chromosome 17 and 18 in breast carcinoma: two new regions identified. Proc Natl Acad Sci USA 87:7737–7741, 1990

    PubMed  Google Scholar 

  21. Morrison BW, Leder P: neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-tumors. Oncogene 9:3417–3426, 1994

    PubMed  Google Scholar 

  22. Adams SM, Helps NR, Sharp MGF, Brammar WJ, Walker RA, Varley JM: Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumours. Human Mol Genet 1:91–96, 1992

    Google Scholar 

  23. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: Isolation of a strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene. Science 250:66–71, 1994

    Google Scholar 

  24. Weiss R, Teich N, Varmus H, Coffin J: Molecular biology of tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor NY, 1982, pp 16–18

    Google Scholar 

  25. Marchetti A, Robbins J, Campbell G, Buttitta F, Squartini F, Bistocchi M, Callahan R: Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of int-1 and int-2 loci in mouse mammary tumors. J Virol 65:4550–4554, 1991

    PubMed  Google Scholar 

  26. Medina D: Preneoplastic lesions in mouse mammary tumorigenesis. Methods Cancer Res 7:3–53, 1973

    Google Scholar 

  27. DeOme KB, Faulkin LJ, Bern HA, Blair PB: Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. J Natl Cancer Inst 78:751–757, 1959

    Google Scholar 

  28. Daniel C, DeOme K, Young L, Blair P, Faulkin L: The in vivo life span of normal and preneoplastic mouse mammary glands: a serial transplantation study. Proc Natl Acad Sci USA 61:53–60, 1968

    PubMed  Google Scholar 

  29. Varmus HE: Recent evidence of oncogenesis by insertional mutagenesis. Cancer Surv 1:309–320, 1982

    Google Scholar 

  30. Dickson C, Smith R, Brookes S, Peters G: Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37:529–536, 1984

    PubMed  Google Scholar 

  31. Nusse R, Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99–109, 1982

    PubMed  Google Scholar 

  32. Peters G, Brookes S, Smith R, Placzek M, Dickson C: The mouse homolog of thehst/k-FGF gene is adjacent toint-2 and activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci USA 86:5678–5682, 1989

    PubMed  Google Scholar 

  33. MacArthur CA, Shankar DB, Shackleford GM: Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol 69:2501–2507, 1995

    PubMed  Google Scholar 

  34. Roelink H, Wagenaar E, Lopes da Silva S, Nusse R: Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Proc Natl Acad Sci USA 87:4519–4523, 1990

    PubMed  Google Scholar 

  35. Klingensmith J, Nusse R: Signaling bywingless in Drosophila. Dev Biol 166:396–414, 1994

    PubMed  Google Scholar 

  36. Nusse R, Varmus HE: Wnt genes. Cell 69:1073–1087, 1992

    PubMed  Google Scholar 

  37. Hinck L, Nathke IS, Papkoff J, Nelson WJ: β-catenin: a common target for the regulation of cell adhesion by Wnt-1 and Src signaling pathways. Trends Biochem Sci 19:538–542, 1994

    PubMed  Google Scholar 

  38. Delli Bovi P, Curatola A, Kern F, Greco A, Ittmann M, Basilico C: An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50:729–737, 1987

    PubMed  Google Scholar 

  39. Dickson C, Peters G: Potential oncogene product related to growth factor. Nature 326:833, 1987

    Google Scholar 

  40. Yoshida T, Miyagawa K, Odagiri H, et al: Genomic sequence ofHst/KS transforming gene encoding a protein homologous to fibroblast growth factors and theInt-2 encoded protein. Proc Natl Acad Sci USA 84:7305–7309, 1987

    PubMed  Google Scholar 

  41. Jakobovits A, Shackelford GM, Varmus HE, Martin GR: Two protooncogenes implicated in mammary carcinogenesis, Int-1 and Int-2, are independently regulated during mouse development. Proc Natl Acad Sci USA 83:7806–7810, 1986

    PubMed  Google Scholar 

  42. Wilkinson DG, Peters G, Dickson G, McMahon AP: Expression of FGF-related proto-oncogene Int-2 during gastrulation and neurulation in the mouse. EMBO J 7:691–695, 1988

    PubMed  Google Scholar 

  43. Basillico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115–164, 1992

    PubMed  Google Scholar 

  44. Goldfarb M: The fibroblast growth factor family. Cell Growth & Diff 1:439–445, 1990

    Google Scholar 

  45. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the Int-1 gene in transgenic mice Is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55:619–625, 1988

    PubMed  Google Scholar 

  46. Muller WJ, Lee FS, Dickson C, Peters G: Theint-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 9:907–913, 1990

    PubMed  Google Scholar 

  47. Stamp G, Fantl V, Poulsom R, Jamieson S, Smith R, Peters G, Dickson C: Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth & Diff 3:929–938, 1992

    Google Scholar 

  48. Kwan H, Pecenka V, Tsukamoto A, Parslow TG, Guzman R, Lin TP, Muller WJ, Lee FS, Leder P, Varmus HE: Transgenes expressing the Wnt-1 and Int-2 proto-oncogenes cooperate during carcinogenesis in doubly transgenic mice. Mol Cell Biol 12:147–154, 1992

    PubMed  Google Scholar 

  49. Shackleford GM, MacArthur CA, Kwan HC, Varmus H: Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proc Natl Acad Sci USA 90:740–744, 1993

    PubMed  Google Scholar 

  50. Lee FS, Lane TF, Kuo A, Shackleford GM, Leder P: Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci USA 92:2268–2272, 1995

    PubMed  Google Scholar 

  51. Parr BA, McMahon AP: Dorsalizing signal Wnt-7a required for normal polarity of D–V and A–P axes of mouse limb. Nature 374:350–353, 1995

    PubMed  Google Scholar 

  52. Yang Y, Niswander L: Interaction between the signaling molecules Wnt7a and SHH during vertebrate limb development: Dorsal signals regulate anterior-posterior patterning. Cell 80:939–947, 1995

    PubMed  Google Scholar 

  53. Christian JL, Olson DJ, Moon RT: XWnt-8 modifies the character of mesoderm induced by bFGF in isolated Xenopus ectoderm. EMBO J 11:33–41, 1992

    PubMed  Google Scholar 

  54. Peters G: Oncogenes at viral integration sites. Cell Growth & Diff 1:503–510, 1990

    Google Scholar 

  55. Schwartz M, Smith G, Medina D: The effect of parity, tumor latency and transplantation on the activation of int loci in MMTV-induced transplanted C3H mammary preneoplasias and their tumors. Int J Cancer 51:805–811, 1992

    PubMed  Google Scholar 

  56. Gallahan D, Escot C, Hogg E, Callahan R: Mammary tumorigenesis in feral species of the genus Mus.In: Potter M (ed) The Wild Mouse in Immunology [Current Topics in Microbiology and Immunology]. Springer Verlag, Heidelberg, 1986

    Google Scholar 

  57. Callahan R, Drohan W, Gallahan D, D'Hoostelaere L, Potter M: Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome. Proc Natl Acad Sci USA 79:4113–4117, 1982

    PubMed  Google Scholar 

  58. Escot C, Hogg E, Callahan R: Mammary tumorigenesis in feral Mus cervicolor popaeus. J Virol 58:619–625, 1986

    PubMed  Google Scholar 

  59. Gallahan D, Callahan R: Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus(CzechII)-induced mammary tumors. J Virol 61:66–74, 1987

    PubMed  Google Scholar 

  60. Gallahan D, Kozak C, Callahan R: A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. J Virol 61:218–220, 1987

    PubMed  Google Scholar 

  61. Siracusa LD, Rosner MH, Vigano MA, Gibert DJ, Staudt LM, Copeland NG, Jenkins NA: Chromosomal location of the octamer transcription factors, Otf-1, Otf-2, and Otf-3, defines multiple Otf-3 -related sequences dispersed in the mouse genome. Genomics 10:313–326, 1991

    PubMed  Google Scholar 

  62. Robbins J, Blondel BJ, Gallahan D, Callahan R: Mouse mammary tumor gene Int-3: a member of the Notch gene family transforms mammary epithelial cells. J Virol 66:2594–2599, 1992

    PubMed  Google Scholar 

  63. Lardelli M, Dahlstrand J, Lendahl U: The novel Notch homolog mouse Notch3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Devel 46:123–136, 1994

    Google Scholar 

  64. Weinmaster G, Roberts VJ, Lemke G: A homolog of Drosophila Notch expressed during mammalian development. Development 113:191–205, 1991

    Google Scholar 

  65. Weinmaster G, Roberts VJ, Lemke G: Notch2: a second mammalian Notch gene. Development 116:931–941, 1992

    PubMed  Google Scholar 

  66. Muskavitch MAT: Delta-Notch signaling and Drosophila cell fate choice. Dev Biol 166:415–430, 1994

    PubMed  Google Scholar 

  67. Struhl G, Fitzgerald K, Greenwald I: Intrinsic activity of the lin-12 and Notch intracellular domains in vivo. Cell 74:331–345, 1993

    PubMed  Google Scholar 

  68. Smith GH, Gallahan D, Diella F, Jhappan C, Merlino G, Callahan R: Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth & Diff, in press

  69. Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino GT, Callahan R: Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes & Diff, in press

  70. Sarkar NH, Haga S, Lehner A, Zhao W, Imai S, Moriwaki k: Insertional mutation of Int protooncogenes in the mammary tumors of a new strain of mice from the wild in China: Normal- and tumor-tissue-specific expression of Int-3 transcripts. Virology 203:52–62, 1994

    PubMed  Google Scholar 

  71. Marchetti A, Buttitta F, Miyazaki S, Gallahan D, Smith GH, Callahan R: Int6, a highly-conserved widely-expressed gene is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol 69:1932–1938, 1995

    PubMed  Google Scholar 

  72. Kordon EC, McKnight R, Jhappan C, Hennighausen L, Merlino G, Smith GH: Ectopic TGFβ1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Devel Biol 168:47–61, 1995

    Google Scholar 

  73. Medina D, Smith GH: In search of mammary gland stem cells. Protoplasma 159:77–84, 1990

    Google Scholar 

  74. Smith G, Medina D: A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci 89:173–183, 1988

    Google Scholar 

  75. Smith G, Gallahan D, Zweibel J, Freeman S, Bassin R, Callahan R: Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells. J Virol 65:6365–6370, 1991

    PubMed  Google Scholar 

  76. Wellings SR: A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Path Res Pract 166:515–535, 1980

    PubMed  Google Scholar 

  77. Roelink H, Wang J, Black DM, Solomon E, Nusse R: Molecular cloning and chromosomal localization to 17q21 of the human WNT3 gene. Genomics 17:790–792, 1993

    PubMed  Google Scholar 

  78. Vande Vijver MJ, Petersen J, Mooi W, Lomans J, Verbruggen M, Vande Bersselaar A, Devilee P, Cornelisse C, Bos JL, Yarnold J, Nusse R: Oncogene activations in human breast cancer.In: Furth M, Greaves M (eds) Molecular Diagnostics of Human Cancer. Cold Spring Harbor Laboratory Press, NY, 1989, pp 385–391

    Google Scholar 

  79. Callahan R, Cropp C, Merlo GR, Diella F, Venesio T, Lidereau R, Cappa APM: Genetic and molecular heterogeneity of breast cancer cells. Clinica Chimica Acta 217:63–73, 1993

    Google Scholar 

  80. Nadeau JH, Davisson MT, Doolittle DP, Grant P, Hillyard AL, Kosowsky MR, Roderick TH: Comparative map for mice and humans. Mam Genome 3:480–536, 1992

    Google Scholar 

  81. Crosley PH, Martin GR: The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121:439–451, 1995

    PubMed  Google Scholar 

  82. Miyazaki S, Kozak CA, Marchetti A, Buttitta F, Gallahan D, Callahan R: The chromosomal location of the mouse mammary tumor gene Int6 and related pseudogenes in the mouse genome. Genomics, in press

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callahan, R. MMTV-induced mutations in mouse mammary tumors: Their potential relevance to human breast cancer. Breast Cancer Res Tr 39, 33–44 (1996). https://doi.org/10.1007/BF01806076

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806076

Key words

Navigation